期刊
INTERNATIONAL JOURNAL OF HYPERTHERMIA
卷 37, 期 3, 页码 76-99出版社
TAYLOR & FRANCIS LTD
DOI: 10.1080/02656736.2020.1800831
关键词
Thermal nanomedicine; bioheat equation; cancer; thermal dose; computational modeling; multicore nanoparticles
资金
- CNPq [310230/2017-9]
- CAPES
- FAPEG [201710267000511]
Magnetic nanoparticle hyperthermia (MNH) is a promising nanotechnology-based cancer thermal therapy that has been approved for clinical use, together with radiation therapy, for treating brain tumors. Almost ten years after approval, few new clinical applications had appeared, perhaps because it cannot benefit from the gold standard noninvasive MRI thermometry technique, since static magnetic fields inhibit heat generation. This might limit its clinical use, in particular as a single therapeutic modality. In this article, we review the in vivo MNH preclinical studies, discussing results of the last two decades with emphasis on safety as a clinical criteria, the need for low-field nano-heaters and noninvasive thermal dosimetry, and the state of the art of computational modeling for treatment planning using MNH. Limitations to more effective clinical use are discussed, together with suggestions for future directions, such as the development of ultrasound-based, computed tomography-based or magnetic nanoparticle-based thermometry to achieve greater impact on clinical translation of MNH.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据